Argus downgraded Elevance Health (ELV) to Hold from Buy.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Elevance Health: Buy Rating Affirmed Amid Growth Potential in Non-HIX Segments and Temporary Earnings Boosts
- Insider Moves: Seagate, Elevance, Appian, AeroVironment, Box
- JPMorgan, Starbucks, HPE, Sarepta, Elevance: Trending by Analysts
- Elevance Health CEO Boudreaux buys $2.44M of shares
- Elevance Health falls -7.2%